NCT05358717: An ongoing trial by PTC Therapeutics
This trial is ongoing. It must report results 2 months, 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05358717 |
|---|---|
| Title | A Phase 2A, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of PTC518 in Subjects With Huntington's Disease |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 25, 2022 |
| Completion date | Feb. 15, 2025 |
| Required reporting date | Feb. 15, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |